Anti-S100A10 antibodies that are bound to liposomes represent a promising strategy in glioma research, as they can specifically target tumor cells while minimizing off-target effects. S100A10 is believed to play a crucial role in the regulation of immune responses within the glioma microenvironment, thus influencing tumor growth and progression. By utilizing liposomes as a drug delivery system, the therapeutic efficacy of these antibodies may be significantly enhanced, allowing for sustained release and improved bioavailability at the tumor site. This innovative approach could not only advance our understanding of glioma biology but also pave the way for more effective treatment modalities in combating this challenging form of brain cancer.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-3883z | Mouse Anti-SYT1 Recombinant Antibody (clone 14H2) | ELISA, IHC, WB | Mouse IgG2a, κ |
MOB-1973MZ | Recombinant Mouse Anti-Rat SYT1 Antibody (clone BTW40) | ICC/IF, WB | Mouse antibody |
VS-0223-WK72 | Rabbit Anti-SYT1 Recombinant Antibody (VS-0223-WK72) | WB, IP, ICC, IHC, IHC-P | Rabbit IgG |
VS-0223-WK73 | Rabbit Anti-SYT1 Recombinant Antibody (VS-0223-WK73) | WB, IP, IHC | Rabbit IgG |
VS-0223-WK74 | Rabbit Anti-SYT1 Recombinant Antibody (VS-0223-WK74) | ICC | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY131. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.